Lessons from the appetite suppressant debacle

    loading  Checking for direct PDF access through Ovid

Abstract

Earlier this year, members of the International Society for Pharmacoepidemiology (ISPE) met together in Boston, US, to discuss the pharmacoepidemiological, pharmacovigilance and regulatory issues surrounding the worldwide withdrawal of the appetite suppressants fenfluramine and dexfenfluramine that occurred in September of last year. An updated session of this meeting was held at the 14th International Conference on Pharmacoepidemiology [Berlin, Germany; August 1998].

Related Topics

    loading  Loading Related Articles